Historical record - last NADAC effective date: 4/22/2015
This NDC is on FDA's drug shortage list (posted Feb 22, 2012)
Reported reason: Other
Product Information
LIDOCAINE 1%-EPI 1:100,000 is a generic product labeled by Hospira Inc., priced at $0.0883 per ML under NDC 00409317801. Its NADAC has been published 95 times since Jul 23, 2014.
FDA first approved this application on Jun 21, 1988. Its Orange Book therapeutic-equivalence code is AP.
Strength
10; 10 ug/mL; mg/mL
Manufacturer
Hospira Inc.NDC
00409317801
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INFILTRATION; PERINEURAL
Effective Date
4/22/2015
Active Ingredients
EPINEPHRINE; LIDOCAINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA089644FDA Approved
6/21/1988
TE Code
AP
On Market Since
9/16/2005
Pharmacological Classes
Price Statistics
The NADAC for LIDOCAINE 1%-EPI 1:100,000 has been published 95 times since Jul 23, 2014, and over the history we have for it it has risen 5.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0883 per ML |
|---|---|
| All-time high | $0.0883 (May 11, 2016) |
| All-time low | $0.0816 (Sep 17, 2014) |
| Median price | $0.0883 |
| Average price | $0.0857 |
| Largest weekly change | +8.3% (Apr 22, 2015) |
| Weeks tracked | 95 |
| Tracking since | Jul 23, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+5.6%
Last surveyed May 11, 2016 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the LIDOCAINE HYDROCHLORIDE and EPINEPHRINE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hospira Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
LIDOCAINE HYDROCHLORIDE and EPINEPHRINE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Amide Local Anesthetic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LIDOCAINE 1%-EPI 1:100,000?
The current National Average Drug Acquisition Cost (NADAC) for LIDOCAINE 1%-EPI 1:100,000, manufactured by Hospira Inc., is $0.0883 per ML (NDC 00409317801), effective May 11, 2016.
How has the price of LIDOCAINE 1%-EPI 1:100,000 changed over time?
Over the history we have for it, the NADAC for LIDOCAINE 1%-EPI 1:100,000 has risen 5.6%. It has been tracked across 95 weekly CMS publications since Jul 23, 2014.
What are the highest and lowest recorded NADAC prices for LIDOCAINE 1%-EPI 1:100,000?
Since Jul 23, 2014, the NADAC for LIDOCAINE 1%-EPI 1:100,000 has ranged from a low of $0.0816 (Sep 17, 2014) to a high of $0.0883 (May 11, 2016), with a median of $0.0883 per ML.
Are there cheaper alternatives to LIDOCAINE 1%-EPI 1:100,000?
No other NADAC-published product currently shares the active ingredient and strength of LIDOCAINE 1%-EPI 1:100,000 in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LIDOCAINE 1%-EPI 1:100,000?
LIDOCAINE 1%-EPI 1:100,000 (NDC 00409317801) is labeled by Hospira Inc., and CMS classifies it as a generic product.
Is LIDOCAINE 1%-EPI 1:100,000 in shortage?
Yes — NDC 00409317801 is currently listed in FDA's drug shortage database (posted Feb 22, 2012). Reported reason: Other.